In MS, dysregulated NF-κB activation has been observed in both peripheral blood immune cells and within active lesions in the CNS [10,11,12,13,14,15,16], and multiple genes within or regulated by the NF-κB pathway have been linked to the development of MS [17]. The gene discussed is NFKB1; the disease is myeloid sarcoma.